Obesity and Body Weight Management
KeyBioscience S.A., through its Nordic Bioscience Endocrinology unit in Lugano, is involved in clinical research centered on obesity and the regulation of body weight. Its trial activity reflects interest in metabolic conditions where weight reduction is clinically relevant.
- Obesity
- Body Weight
- Metabolic Health
The sponsor’s research footprint includes active studies across multiple countries and collaboration with several research sites in Europe.
Knee Osteoarthritis and Joint Pain
The sponsor also focuses on knee osteoarthritis, with particular attention to joint pain and symptoms that affect mobility and daily function. This therapeutic area links musculoskeletal disease with weight-related clinical concerns.
- Knee Osteoarthritis
- Joint Pain
- Mobility
Clinical interest in this area is directed toward patients experiencing both degenerative joint disease and excess body weight.
Endocrinology and Metabolic Disease
As a pharmaceutical sponsor with an endocrinology-focused function, KeyBioscience S.A. is engaged in research at the intersection of endocrinology, metabolic disease, and musculoskeletal disorders. The trial portfolio indicates attention to conditions where hormonal and metabolic factors influence clinical outcomes.
- Endocrinology
- Metabolic Disease
- Musculoskeletal Health
This area connects metabolic regulation with symptom burden in chronic disease settings.
